APA

Allouchery V., Beaussire L., Perdrix A., Sefrioui D., Augusto L., Guillemet C., Sarafan-Vasseur N., Di Fiore F. & Clatot F. (20190508). Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. : Breast cancer research : BCR.

Chicago

Allouchery Violette, Beaussire Ludivine, Perdrix Anne, Sefrioui David, Augusto Laetitia, Guillemet Cécile, Sarafan-Vasseur Nasrin, Di Fiore Frédéric and Clatot Florian. 20190508. Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. : Breast cancer research : BCR.

Harvard

Allouchery V., Beaussire L., Perdrix A., Sefrioui D., Augusto L., Guillemet C., Sarafan-Vasseur N., Di Fiore F. and Clatot F. (20190508). Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. : Breast cancer research : BCR.

MLA

Allouchery Violette, Beaussire Ludivine, Perdrix Anne, Sefrioui David, Augusto Laetitia, Guillemet Cécile, Sarafan-Vasseur Nasrin, Di Fiore Frédéric and Clatot Florian. Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. : Breast cancer research : BCR. 20190508.